|

RMC-5552 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: mTORC1/4EBP1

Pipeline

Phase 1: 1

Top Sponsors

  • Nicholas Butowski1

Indications

  • Recurrent Glioblastoma1
  • Glioblastoma1
  • Cancer1

San Francisco, California1 trial

RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma

University of California, San Francisco

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.